AbstractAggregation of expanded polyglutamine (polyQ) seems to be the cause of various genetic neurodegenerative diseases. Relatively little is known as yet about the polyQ structure and the mechanism that induces aggregation. We have characterised the solution structure of polyQ in a proteic context using a model system based on glutathione S-transferase fusion proteins. A wide range of biophysical techniques was applied. For the first time, nuclear magnetic resonance was used to observe directly and selectively the conformation of polyQ in the pathological range. We demonstrate that, in solution, polyQs are in a random coil conformation. However, under destabilising conditions, their aggregation behaviour is determined by the polyQ length
AbstractA common thread connecting nine fatal neurodegenerative protein aggregation diseases is an a...
Nine neurodegenerative disorders, referred to as polyglutamine diseases and including Huntington’s d...
A growing number of neurodegenerative diseases are caused by expansion of CAG trinucleotide repeats ...
AbstractAggregation of expanded polyglutamine (polyQ) seems to be the cause of various genetic neuro...
Expanded polyglutamine (polyQ) tracts in proteins, which are known to induce their aggregation, are ...
AbstractPolyglutamine (polyQ) expansion leads to protein aggregation and neurodegeneration in Huntin...
Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by the expansion of ...
Protein misfolding and aggregation is a pathogenic feature shared among at least ten polyglutamine (...
Protein misfolding as a result of polyglutamine (polyQ) repeat expansion plays a crucial role in the...
Exonic CAG repeat diseases are a class of neurodegenerative age-of-onset diseases caused by an unsta...
Polyglutamine is a naturally occurring peptide found within several proteins in neuronal cells of th...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
Expansions of polyglutamine (polyQ) tracts in nine different proteins cause a family of neurodegener...
Expansion of polyglutamine (polyQ) tracts in proteins results in protein aggregation and is associat...
AbstractA common thread connecting nine fatal neurodegenerative protein aggregation diseases is an a...
Nine neurodegenerative disorders, referred to as polyglutamine diseases and including Huntington’s d...
A growing number of neurodegenerative diseases are caused by expansion of CAG trinucleotide repeats ...
AbstractAggregation of expanded polyglutamine (polyQ) seems to be the cause of various genetic neuro...
Expanded polyglutamine (polyQ) tracts in proteins, which are known to induce their aggregation, are ...
AbstractPolyglutamine (polyQ) expansion leads to protein aggregation and neurodegeneration in Huntin...
Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by the expansion of ...
Protein misfolding and aggregation is a pathogenic feature shared among at least ten polyglutamine (...
Protein misfolding as a result of polyglutamine (polyQ) repeat expansion plays a crucial role in the...
Exonic CAG repeat diseases are a class of neurodegenerative age-of-onset diseases caused by an unsta...
Polyglutamine is a naturally occurring peptide found within several proteins in neuronal cells of th...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
Expansions of polyglutamine (polyQ) tracts in nine different proteins cause a family of neurodegener...
Expansion of polyglutamine (polyQ) tracts in proteins results in protein aggregation and is associat...
AbstractA common thread connecting nine fatal neurodegenerative protein aggregation diseases is an a...
Nine neurodegenerative disorders, referred to as polyglutamine diseases and including Huntington’s d...
A growing number of neurodegenerative diseases are caused by expansion of CAG trinucleotide repeats ...